These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24720326)

  • 1. Prophylaxis for thromboembolic disease and evaluation for thrombophilia.
    Westrich GH; Dlott JS; Cushner FD; Johanson NA; Ruel AV
    Instr Course Lect; 2014; 63():409-19. PubMed ID: 24720326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
    Lieberman JR; Pensak MJ
    J Bone Joint Surg Am; 2013 Oct; 95(19):1801-11. PubMed ID: 24088973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolic disease after total hip and knee arthroplasty.
    Haas SB; Barrack RL; Westrich G
    Instr Course Lect; 2009; 58():781-93. PubMed ID: 19385586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution.
    Lewis CG; Inneh IA; Schutzer SF; Grady-Benson J
    J Bone Joint Surg Am; 2014 Aug; 96(16):1327-32. PubMed ID: 25143492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism: management by American Association of Hip and Knee Surgeons.
    Markel DC; York S; Liston MJ; Flynn JC; Barnes CL; Davis CM;
    J Arthroplasty; 2010 Jan; 25(1):3-9.e1-2. PubMed ID: 19837560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Current Review of Mechanical Compression and Its Role in Venous Thromboembolic Prophylaxis in Total Knee and Total Hip Arthroplasty.
    Pierce TP; Cherian JJ; Jauregui JJ; Elmallah RK; Lieberman JR; Mont MA
    J Arthroplasty; 2015 Dec; 30(12):2279-84. PubMed ID: 26048728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing and contrasting current guidelines for venous thromboembolism prophylaxis after total hip and total knee arthroplasty.
    Lachiewicz PF
    Instr Course Lect; 2011; 60():301-7. PubMed ID: 21553782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous Thromboembolism Prophylaxis in Total Hip Arthroplasty and Total Knee Arthroplasty Patients: From Guidelines to Practice.
    Lieberman JR; Heckmann N
    J Am Acad Orthop Surg; 2017 Dec; 25(12):789-798. PubMed ID: 29176502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolic disease reduction with a portable pneumatic compression device.
    Froimson MI; Murray TG; Fazekas AF
    J Arthroplasty; 2009 Feb; 24(2):310-6. PubMed ID: 18534456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.
    Friedman RJ; Sengupta N; Lees M
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):299-306. PubMed ID: 21671699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis for Venous Thromboembolic Events in Elective Total Hip and Total Knee Arthroplasty.
    Karasavvidis T; Bouris V; Xiang W; Tzavellas G; Charisis N; Palaiodimos L; Kigka V; Bourantas CV; Gkiatas I
    Curr Pharm Des; 2022; 28(10):771-777. PubMed ID: 35440299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's New in Venous Thromboembolic Prophylaxis Following Total Knee and Total Hip Arthroplasty? An Update.
    Pierce TP; Elmallah RK; Jauregui JJ; Cherian JJ; Mont MA
    Surg Technol Int; 2015 May; 26():234-7. PubMed ID: 26055015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence.
    Stewart DW; Freshour JE
    Ann Pharmacother; 2013 Jan; 47(1):63-74. PubMed ID: 23324504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimen.
    Dahl OE
    Clin Appl Thromb Hemost; 2009; 15 Suppl 1():17S-24S. PubMed ID: 19696041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.
    Eriksson BI; Friedman RJ
    Clin Appl Thromb Hemost; 2009; 15 Suppl 1():25S-31S. PubMed ID: 19648146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.